Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG MedAvanteProPhase, explains why this is the case. She also discusses, among other topics, how clinical trial metrics haven’t always kept pace with scientific innovation.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Ideal vs. Reality Budgeting - Create & Negotiate the Best Clinical Trial Budget for Your Site
No Longer an Afterthought - A Call for Greater Diversity and Inclusion in Clinical Trials
